Brightstar Partners

The Brightstar team combines a long history of early stage technology spin-outs from corporate labs and institutions, together with many years’ experience as hands-on serial technology entrepreneurs. With strong skills in strategy, IP commercialisation, corporate finance, negotiations, structuring and legals, Brightstar brings much needed skills and experience to very early opportunities, helping them refine their propositions and develop better and more effective commercialisation strategies.

Harry Oh

Managing Partner

1 past transactions

Regenerys

Venture Round in 2016
Regenerys develops and sells regenerative medicine products in the streams requiring bioprocessing and biostorage. It offers Myskin, a product for the autologous treatment of serious burns and difficult to heal wounds using cultured allegoneic cells from the patient’s own skin; and Cryoskin, a medicine for the treatment of burns using autologous cells. Regenerys also provides Adiposet, a service to facilitate better cosmetic outcomes in breast cancer surgery and other cosmetic procedures by enabling the storage and return of adipose tissue for lipomodellin. In addition, it offers third party bio-processing and bio-storage services through its laboratories. Regenerys serves NHS and private healthcare providers in the United Kingdom and other parts of Europe. It began operation in 2011, with its headquarters in Cambridge in the United Kingdom.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.